NL-OMON31922已完成不适用
on invasive imaging of [18F] HX-4 with Positron-Emission-Tomography (PET): A phase I trial - HX4-fase I
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Histological or cytological confirmed solid tumour, primary or secondary stage IV and/ or tumours with no curative treatment options.
- •- WHO performance status 0 to 1
- •- Normal white blood cell count and formula
- •- Normal platelet count
- •- No anaemia requiring blood transfusion or erythropoietin
- •- Adequate hepatic function.
- •- Calculated Creatinin clearance at least 60 ml/min
- •- No administration of Fluor-18 in the previous 24 hours
- •- The patient is capable of complying with study procedures
- •- 18 years or older
排除标准
- •- Recent (< 3 months) myocardial infarction
- •- Uncontrolled infectious disease
- •- Less than 18 years old
- •- pregnant by testing patient with a serum or urine test within 24 hours of receiving 18F-Hx4
- •- No concurrent anti-cancer agents or radiotherapy allowed.
研究者
相似试验
进行中（未招募）
1 期
HX4 in Head and Neck Cancer.EUCTR2011-001812-80-NLMaastro Clinic24
撤回
2 期
on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer.cervix cancer10038594NL-OMON37407Medisch Universitair Ziekenhuis Maastricht20
已完成
2 期
on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer.Cancer of the Head and NeckSquamous cell carcinomas of head and neck10027655NL-OMON39184Medisch Universitair Ziekenhuis Maastricht24
已完成
2 期
on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Cervix Cancer.cervix cancer10038594NL-OMON44375MAASTRO clinic38
进行中（未招募）
1 期
HX4 in cervix cancerEUCTR2014-000224-17-NLMAASTRO Clinic20